A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.
Compared with placebo, once-weekly semaglutide significantly reduced body weight, knee osteoarthritis ... sustainable treatment options for those living with obesity-related osteoarthritis ...
“Obesity-related knee osteoarthritis is a progressive condition ... There is a significant need for non-surgical and sustainable treatment options for those living with obesity-related ...
Treatment with other antiobesity medications was not permitted; the use of other interventions for knee osteoarthritis was permitted. Although pain medication could be used throughout the trial ...